Oric Pharmaceuticals annual net debt
2020
2021
2022
2023
2024
2025
Oric Pharmaceuticals Net Debt Growth & History (ORIC)
Oric Pharmaceuticals's net debt was −$38.2M for fiscal 2025.
View full Oric Pharmaceuticals company overviewOric Pharmaceuticals annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$38.2M | $11.8M | — |
| 2024 | 2024-12-31 | −$50.0M | −$36.9M | — |
| 2023 | 2023-12-31 | −$13.2M | $41.6M | — |
| 2022 | 2022-12-31 | −$54.7M | $148.3M | — |
| 2021 | 2021-12-31 | −$203.1M | −$124.6M | — |
| 2020 | 2020-12-31 | −$78.4M | — | — |
Oric Pharmaceuticals quarterly net debt
Q4.20
Q1.21
Q2.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$34.2M | $38.4M | — |
| Q1 2026 | 2026-03-31 | −$53.1M | −$7.0M | — |
| Q4 2025 | 2025-12-31 | −$38.2M | $11.8M | — |
| Q3 2025 | 2025-09-30 | −$46.4M | −$5.3M | — |
| Q2 2025 | 2025-06-30 | −$72.6M | −$25.5M | — |
| Q1 2025 | 2025-03-31 | −$46.1M | $7.5M | — |
| Q4 2024 | 2024-12-31 | −$50.0M | −$36.9M | — |
| Q3 2024 | 2024-09-30 | −$41.1M | −$17.6M | — |
| Q2 2024 | 2024-06-30 | −$47.1M | $53.9M | — |
| Q1 2024 | 2024-03-31 | −$53.6M | $2.7M | — |
| Q4 2023 | 2023-12-31 | −$13.2M | $41.6M | — |
| Q3 2023 | 2023-09-30 | −$23.5M | $2.9M | — |
| Q2 2023 | 2023-06-30 | −$101.0M | −$54.5M | — |
| Q1 2023 | 2023-03-31 | −$56.3M | $54.3M | — |
| Q4 2022 | 2022-12-31 | −$54.7M | $148.3M | — |
| Q3 2022 | 2022-09-30 | −$26.4M | — | — |
| Q2 2022 | 2022-06-30 | −$46.5M | $122.0M | — |
| Q1 2022 | 2022-03-31 | −$110.6M | −$8.5M | — |
| Q4 2021 | 2021-12-31 | −$203.1M | −$124.6M | — |
| Q2 2021 | 2021-06-30 | −$168.5M | — | — |
| Q1 2021 | 2021-03-31 | −$102.1M | — | — |
| Q4 2020 | 2020-12-31 | −$78.4M | — | — |
Oric Pharmaceuticals net debt trends
Over the last five fiscal years, Oric Pharmaceuticals's net debt increased from −$78.4M to −$38.2M, a change of $40.2M. The latest reported quarter, Q2 2026, shows −$34.2M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Oric Pharmaceuticals source filings ↗